Stock Trend Analysis Report
Prepared for you on Saturday, August 13, 2022.
Statera Biopharma, Inc. (NASDAQ:STAB)
Crossroads (+60) - STAB is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid STAB?
MarketClub looks at technical strength and momentum to determine if the timing is right for STAB.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for STAB
The long-term trend has been DOWN since Sep 20th, 2021 at 3.0800
The intermediate-term trend has been UP since Aug 11th, 2022 at 0.2599
The short-term trend has been UP since Aug 3rd, 2022 at 0.2245
Smart Scan Analysis for STAB
Based on our trend formula, STAB is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|52wk High||4.66||52wk High Date||2021-09-07|
|52wk Low||0.2005||52wk Low Date||2022-07-29|
|Average Volume||564,632||Shares Outstanding||32,096|